日本フィジカルAI新聞

世界のフィジカルAIを、日本語で。

週刊ニュースレター購読
医療画像生成/因果推論arXiv:2610.26923

CaMeWM:腫瘍進展と治療計画のための因果的医療ワールドモデル

CaMeWM: A Causal Medical World Model for Generative Tumor Evolution and Treatment Planning

シェア:XThreadsFacebookLINEはてブBluesky

TACE後の腫瘍進展を因果的に生成し、治療レジメン間の反事実的比較を可能にする医療ワールドモデルを提案。生成したフォローアップCTと生存時間予測を統合し治療計画を支援する。

著者: Huanlong Gao, Xuelei He, Fengjun Zhao, Xiaowei He

分類: cs.CV, cs.LG

原文アブストラクト

Treatment planning is intrinsically counterfactual: clinicians must compare how a patient's tumor and survival would evolve under competing regimens, whereas a retrospective cohort records only the regimen received and one follow-up scan. A treatment-conditioned generator trained on such data can therefore reproduce historical treatment allocation rather than simulate the interventional disease dynamics needed to rank regimens. We introduce \textbf{CaMeWM}, a causal medical world model for supported post-TACE tumor evolution and treatment planning. CaMeWM implements one intervention-to-decision loop rather than three independent prediction tasks: it first admits a queried regimen only for clinically comparable histories with empirical treatment support; it then generates a distribution of lesion-local follow-up worlds through an action-conditioned response descriptor, deterministic anchor, and residual 3D diffusion transition; and it finally maps sampled worlds to restricted mean survival time (RMST) with a response-Cox utility model. Under pre-treatment adjustment and positivity, this loop estimates a prespecified, support-restricted g-formula target; all selection and nuisance estimation are fold-local, and the induced policy is evaluated by cross-fitted, censoring-adjusted doubly robust estimation. Across 79 paired out-of-fold episodes, CaMeWM achieves 0.618 SSIM and 0.528 change-map SSIM for follow-up CT transition, while its generated-world survival pathway attains a 0.615 C-index; factual-only AIPW estimates a 9.60-week RMST gain (95\% CI 0.61--18.13) for the frozen policy. CaMeWM provides an inspectable basis for retrospective, support-restricted treatment planning.

PR本紙発行元 EmplifAI